BMRN
Biomarin Pharmaceutical Inc
NASDAQ: BMRN · HEALTHCARE · BIOTECHNOLOGY
$54.21
+1.71% today
Updated 2026-04-29
Market cap
$10.48B
P/E ratio
30.12
P/S ratio
3.25x
EPS (TTM)
$1.80
Dividend yield
—
52W range
$51 – $66
Volume
2.0M
Biomarin Pharmaceutical Inc (BMRN) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $84.21M | $121.58M | $296.49M | $324.66M | $376.27M | $441.36M | $500.72M | $548.49M | $749.28M | $889.89M | $1.12B | $1.31B | $1.49B | $1.70B | $1.86B | $1.85B | $2.10B | $2.42B | $2.85B | $3.22B |
| Revenue growth (YoY) | — | +44.4% | +143.9% | +9.5% | +15.9% | +17.3% | +13.5% | +9.5% | +36.6% | +18.8% | +25.5% | +17.6% | +13.5% | +14.3% | +9.2% | -0.8% | +13.5% | +15.4% | +18.0% | +12.9% |
| Cost of revenue | $8.74M | $18.36M | $52.51M | $65.91M | $70.28M | $84.02M | $91.83M | $88.39M | $122.27M | $152.01M | $209.62M | $241.79M | $315.26M | $359.47M | $524.27M | $470.51M | $503.02M | $532.06M | $580.24M | $736.83M |
| Gross profit | $75.47M | $103.22M | $243.98M | $258.75M | $305.98M | $357.33M | $408.89M | $460.09M | $627.02M | $737.89M | $907.23M | $1.07B | $1.18B | $1.34B | $1.34B | $1.38B | $1.59B | $1.89B | $2.27B | $2.48B |
| Gross margin | 89.6% | 84.9% | 82.3% | 79.7% | 81.3% | 81.0% | 81.7% | 83.9% | 83.7% | 82.9% | 81.2% | 81.6% | 78.9% | 78.9% | 71.8% | 74.5% | 76.0% | 78.0% | 79.7% | 77.1% |
| R&D | $66.73M | $78.60M | $93.29M | $115.12M | $147.31M | $214.37M | $302.22M | $354.78M | $461.54M | $634.81M | $661.90M | $610.75M | $696.33M | $715.01M | $628.12M | $628.79M | $649.61M | $746.77M | $747.18M | $921.93M |
| SG&A | $49.03M | $77.54M | $106.57M | $124.29M | $151.72M | $175.42M | $198.17M | $235.36M | $302.16M | $402.27M | $476.59M | $554.34M | $280.20M | $298.70M | $334.30M | $354.30M | $372.90M | $404.00M | $532.30M | $1.15B |
| Operating income | $-24.67M | $-57.29M | $39.76M | $16.43M | $544000.00 | $-33.89M | $-110.22M | $-156.01M | $-92.89M | $-110.70M | $-803.43M | $-14.70M | $-123.52M | $-100.46M | $-43.44M | $-82.34M | $160.97M | $185.77M | $484.21M | $533.48M |
| Operating margin | -29.3% | -47.1% | 13.4% | 5.1% | 0.1% | -7.7% | -22.0% | -28.4% | -12.4% | -12.4% | -71.9% | -1.1% | -8.3% | -5.9% | -2.3% | -4.5% | 7.7% | 7.7% | 17.0% | 16.6% |
| EBITDA | $-14.88M | $-52.92M | $67.43M | $35.63M | $17.07M | $-172000.00 | $-67.26M | $-131.12M | $-45.69M | $-72.59M | $-698.01M | $90.97M | $-3.37M | $31.92M | $83.66M | $47.43M | $265.36M | $306.77M | $650.53M | $572.94M |
| EBITDA margin | -17.7% | -43.5% | 22.7% | 11.0% | 4.5% | -0.0% | -13.4% | -23.9% | -6.1% | -8.2% | -62.5% | 6.9% | -0.2% | 1.9% | 4.5% | 2.6% | 12.7% | 12.7% | 22.8% | 17.8% |
| EBIT | $-24.67M | $-54.01M | $49.82M | $14.66M | $-10.67M | $-35.22M | $-111.60M | $-167.13M | $-91.56M | $-119.77M | $-794.92M | $3.11M | $-99.04M | $-73.38M | $-21.52M | $-60.61M | $163.39M | $202.39M | $554.10M | $493.38M |
| Interest expense | $16.73M | $14.24M | $16.39M | $14.09M | $10.33M | $8.35M | $7.64M | $10.45M | $36.64M | $38.24M | $39.50M | $42.71M | $43.66M | $23.46M | $29.31M | $15.34M | $15.97M | $17.34M | $12.67M | $10.90M |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-28.53M | $-15.80M | $30.83M | $-488000.00 | $205.82M | $-53.84M | $-114.35M | $-176.35M | $-133.97M | $-171.80M | $-630.21M | $-117.04M | $-77.21M | $-23.85M | $854.03M | $-64.08M | $141.56M | $167.65M | $426.86M | $348.90M |
| Net income growth (YoY) | — | +44.6% | +295.1% | -101.6% | +42276.0% | -126.2% | -112.4% | -54.2% | +24.0% | -28.2% | -266.8% | +81.4% | +34.0% | +69.1% | +3681.1% | -107.5% | +320.9% | +18.4% | +154.6% | -18.3% |
| Profit margin | -33.9% | -13.0% | 10.4% | -0.2% | 54.7% | -12.2% | -22.8% | -32.2% | -17.9% | -19.3% | -56.4% | -8.9% | -5.2% | -1.4% | 45.9% | -3.5% | 6.8% | 6.9% | 15.0% | 10.8% |